Based on recent data, Evommune, Inc. (EVMN) shows an Average True Range (ATR) of 3.21 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 640.99K, indicating liquidity. These fundamental metrics provide insight into EVMN's underlying financial health and market activity.
| ATR | 3.21 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 640.99K |
| Avg Vol (10 Days) | 460.85K |
Evommune, Inc. (EVMN) technical indicators as of March 25, 2026: the SMA 20 is 7.47%, SMA 50 at 28.22%, and SMA 200 at 30.82%. The RSI 14 value is 54.91, suggesting its current momentum. These technical analysis signals help assess EVMN's price trends and potential future movements.
| SMA 20 | 7.47% |
| SMA 50 | 28.22% |
| SMA 200 | 30.82% |
| RSI 14 | 54.91 |
Evommune, Inc. (EVMN) stock performance overview as of March 25, 2026: The 52-week high is N/A (currently -19.79% below), and the 52-week low is N/A (currently 91.79% above). Over the past year, EVMN's performance is N/A, compared to the S&P 500's 14.52% change.
| 52-Week High | N/A |
| 52-Week High Chg | -19.79% |
| 52-Week Low | N/A |
| 52-Week Low Chg | +91.79% |
| S&P 500 52-Week Chg | 14.52% |
According to current financial data, EVMN stock's P/E (TTM) ratio is -9.72, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for EVMN, including P/S (21.02), P/B (3.26), and P/FCF (-3.56), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | EVMN | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -9.72 | -1.23 | -5.16 | 32.59 |
| P/S (TTM) | 21.02 | 3.71 | 464.92 | 5.98 |
| P/B (TTM) | 3.26 | 7.39 | 4.54 | 4.69 |
| P/FCF (TTM) | -3.56 | 57.23 | -222.17 | 32.63 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep